ライフサイエンスコーパス: arteriovenous fistula

1 er demonstrating right T7 to T8 spinal dural arteriovenous fistula.

2 n objective was the salvage of a functioning arteriovenous fistula.

3 nce angiography of his abdominal vessels and arteriovenous fistula.

4 lysis for the treatment of thrombosed native arteriovenous fistula.

5 edure for the treatment of thrombosed native arteriovenous fistula.

6 implemented an incentive if patients use an arteriovenous fistula.

7 as angiosarcomas might be correlated with an arteriovenous fistula.

8 nts, 20% of sarcomas arose at the site of an arteriovenous fistula.

9 ral sinus anatomy in two patients with dural arteriovenous fistula.

10 ge, cerebrovascular malformations, and dural arteriovenous fistula affecting the basal ganglia, their

11 ux hemodialysis may benefit patients with an arteriovenous fistula and patients with diabetes and tha

12 Arteriovenous fistulas and pseudoaneurysms concerning in

13 Findings included aneurysms, ectasia, arteriovenous fistulas, and anomalous origins.

14 ures observed in dysfunctional, hemodialysis arteriovenous fistulas, and that venous neointimal hyper

15 Although arteriovenous fistulas are considered superior to grafts

16 ssociations between type of vascular access (arteriovenous fistula, arteriovenous graft, and central

17 Clinical practice guidelines recommend an arteriovenous fistula as the preferred vascular access f

18 1.2, mean hemoglobin > or = 11 g/dL, and an arteriovenous fistula as their vascular access.

19 In arteriovenous malformations and dural arteriovenous fistulas, ASL is very sensitive to detect

20 vascular lesions such as pseudoaneurysms and arteriovenous fistulas associated with the internal pude

21 of patients 3 months after implantation) for arteriovenous fistulas, averaged across all patient popu

22 Arteriovenous fistula (AVF) access improves survival in

23 mes have been established with the use of an arteriovenous fistula (AVF) at first hemodialysis.

24 CorMatrix wrapped around the outflow vein of arteriovenous fistula (AVF) at the time of creation coul

25 et al., published the first occurrence of an arteriovenous fistula (AVF) in a transplanted allograft

26 patients initiate hemodialysis (HD) with an arteriovenous fistula (AVF) in countries with universal

27 Arteriovenous fistula (AVF) is the preferred type of vas

28 Arteriovenous fistula (AVF) is the preferred vascular ac

29 Arteriovenous fistula (AVF) maturation failure is the pr

30 of the competing risk of death, high rate of arteriovenous fistula (AVF) maturation failure, and poor

31 Low rates of arteriovenous fistula (AVF) maturation prevent optimal f

32 and subsequently undergo placement of a new arteriovenous fistula (AVF) or arteriovenous graft (AVG)

33 enefit when initiating hemodialysis (HD) via arteriovenous fistula (AVF) or arteriovenous graft (AVG)

34 c variability in both incident and prevalent arteriovenous fistula (AVF) use among patients with ESRD

35 Arteriovenous fistula (AVF) was created in C57BL/J6 mice

36 percent were dialyzed through an autologous arteriovenous fistula (AVF), 49% through a prosthetic gr

37 senting at least one cerebral or spinal pial arteriovenous fistula (AVF), and to describe their clini

38 g incident dialysis patients: (1) placing an arteriovenous fistula (AVF1st) as the initial access fol

39 primary patency rates at 1 year were 16% for arteriovenous fistulas (AVFs) and 23% for polytetrafluor

40 ntima formation causes the failure of 60% of arteriovenous fistulas (AVFs) within 2 years.

41 ces the frequency of early thrombosis of new arteriovenous fistulas but does not increase the proport

42 e prognosis when compared with those with an arteriovenous fistula, but the role of vascular access (

43 ing primary radiocephalic or brachiocephalic arteriovenous fistula creation were randomly assigned (1

44 are causes of tinnitus include cranial dural arteriovenous fistulas (DAVFs), which are usually small

45 x (CVR) in patients with lateral sinus dural arteriovenous fistulas (DAVFs).

46 The relative rate of thrombosis of native arteriovenous fistulas for the highest quartile of intra

47 error, interobserver variability, bleeding, arteriovenous fistula, graft loss, and even death.

48 left heart failure, high cardiac output from arteriovenous fistula, hypoxic lung diseases, and metabo

49 of MCP-1 occurs in the venous segment of an arteriovenous fistula in rodents, and this vasculopathic

50 nalyzed the changes that evolve in a femoral arteriovenous fistula in the rat.

51 Dural arteriovenous fistula is a very rare cause of myelitis t

52 Native arteriovenous fistula is one of the important routes for

53 The arteriovenous fistula is the preferred type of vascular

54 We conclude that this arteriovenous fistula model recapitulates the salient fe

55 n the venous segment of a murine model of an arteriovenous fistula, monocyte chemoattractant protein-

56 ovenous malformations (n = 3), and vertebral arteriovenous fistula (n = 1) underwent therapeutic embo

57 asation (n = 14), pseudoaneurysm (n= 2), and arteriovenous fistula (n = 1).

58 low was generated by construction of femoral arteriovenous fistulas on both sides.

59 at were positive for true or false aneurysm, arteriovenous fistula or malformation, or hemorrhage whe

60 effect on mortality of programmed VA (PVA), (arteriovenous fistula or PTFE graft) and nonprogrammed V

61 nd angiography revealed a pseudoaneurysm and arteriovenous fistula originating from the right interna

62 The primary endpoint was arteriovenous fistula patency at 3 months.

63 with local anaesthesia improved medium-term arteriovenous fistula patency.

64 evelopment include carotid body ablation and arteriovenous fistula placement.

65 nts needing hemodialysis are advised to have arteriovenous fistulas rather than catheters because of

66 alendar year with elective open AAA repairs, arteriovenous fistula repairs, or carotid endarderectomy

67 lar complications, including pseudoaneurysm, arteriovenous fistula, retroperitoneal hematoma, femoral

68 t pulsatile tinnitus caused by a small dural arteriovenous fistula revealed in computed tomography an

69 es after ligation injury and in failed human arteriovenous fistula samples after occlusion by dediffe

70 llow-up clinically and radiologically, dural arteriovenous fistulas should be kept in mind in the eti

71 Complications are less frequent with arteriovenous fistulas than with synthetic grafts.

72 tained vascular injuries (pseudoaneurysms or arteriovenous fistulas) that can be treated electively o

73 s thrombosis and dysfunction of hemodialysis arteriovenous fistulas, the latter caused, in part, by t

74 istered via central line, vascular shunt, or arteriovenous fistula to avoid thrombophlebitis.

75 the lower risk of mortality associated with arteriovenous fistula use in hemodialysis patients is du

76 Arteriovenous fistula use increased only minimally, from

77 , may contribute to the limited longevity of arteriovenous fistulas used for hemodialysis.

78 Arteriovenous fistula utilization at initial hemodialysi

79 In mice with a surgical arteriovenous fistula, volume overload and LV dilation w

80 Type of permanent vascular access (arteriovenous fistula vs synthetic graft), analyzed usin

81 model, venous neointimal hyperplasia in the arteriovenous fistula was also exacerbated.

82 Finally, in a rat model of an arteriovenous fistula, we localized expression of MCP-1

83 jacent to vessels, and PSAs with concomitant arteriovenous fistula were referred to MC (n=145, 34%).

84 -dependent when waitlisted, individuals with arteriovenous fistulas were significantly less likely th

85 ith the low-flux group for the subgroup with arteriovenous fistulas, which constituted 82% of the stu

86 d by a kink, complete venous thrombosis, and arteriovenous fistula with pseudoaneurysm formation.